Elsevier

Seminars in Immunology

Volume 20, Issue 2, April 2008, Pages 117-122
Seminars in Immunology

Review
The effect of three-dimensional matrix-embedding of endothelial cells on the humoral and cellular immune response

https://doi.org/10.1016/j.smim.2007.12.005Get rights and content

Abstract

The endothelium is a unique immunologic target. The first host–donor reaction in any cell, tissue or organ transplant occurs at the blood–tissue interface, the endothelium. When endothelial cells are themselves the primary component of the implant a second set of immunologic reactions arises. Injections of free endothelial cell implants elicit a profound major histocompatibility complex (MHC) II dominated immune response with significant sensitivity, cascade enhancement and immune memory. Endothelial cells embedded within three-dimensional matrices retain all the biosecretory capacity of quiescent endothelial cells. Perivascular implants of such cells are the most potent inhibitor of intimal hyperplasia and thrombosis following controlled vascular injury, but without any immune reactivity. Allo- and even xenogeneic endothelial cells evoke no significant humoral or cellular immune response in immunocompetent hosts when embedded within matrices. Moreover, endothelial implants are immunomodulatory, reducing the extent of the memory response to previous free cell implants. Attenuated immunogenicity results in muted activation of adaptive and innate immune cells.

These findings point toward a pivotal role of matrix–cell-interconnectivity for the cellular immune phenotype and might therefore assist in the design of extracellular matrix components for successful tissue engineering.

Introduction

The artery is an intensely sensitive organ, and its trilaminar architecture is an essential determining component of its ability to maintain vascular homeostasis. The intact blood vessel is thromboresistant, balances vascular tone with patent flow and initiates cascades of repair without impinging on the lumen. The vascular endothelium, covering nearly 700 m2 in the average person, is the luminal lining of the blood vessels in the body and detects minute changes in the local environment [1]. The endothelium not only serves as a simple physical barrier between circulating (immune) cells, metabolites and the underlying tissue but actively regulates vasomotor tone, thrombogenicity, proliferation and interaction with immune cells of adaptive and innate lineage. In the usual quiescent state, turnover rates of endothelial cells are on the order of months to years, but these cells are easily damaged by mechanical, oxidative, metabolic, and immunologic stressors [1]. Over a century ago, Virchow recognized endothelial dysfunction as one of the triad of elements essential for loss of vascular homeostasis and thrombotic occlusion. Each phase of the vascular response to injury: thrombosis, inflammation, cellular proliferation, and vascular remodeling, is influenced if not controlled by the endothelium [2]. Environmental exposure classically contributed to endothelial injury. More recently therapeutic techniques such as balloon angioplasty, endovascular stent implantation, and vascular surgery all significantly impair the integrity of the endothelium as an intact monolayer [2], [3]. Endothelial dysfunction with endothelial cell immune activation, increased leakiness, apoptosis and angiogenesis has been demonstrated for a wide variety of diseases, including rheumatoid arthritis, psoriasis, multiple sclerosis, gut inflammation, chronic lung disease, diabetes, and atherosclerosis [4], [5], [6], [7], [8].

Section snippets

Endothelial cells and immune response

Inflammatory changes of the endothelium favor local recruitment of leukocytes, and transendothelial migration of monocytes and T cells into the subintimal space, which is a fundamental step in the response to tissue-invading microbes and antigens. When this phase is overexuberant significant damage can occur. Indeed, leukocyte infiltration is a crucial initiating step in the development of atheroma within the vessel wall. Endothelial immune behavior is tightly regulated. Recruitment and

Three-dimensional matrix-embedding of endothelial cells

It is increasingly evident that organ tissues yield significant control over local immune reactions and cell behavior [19]. As such three-dimensional cell culture systems offer a milieu to study endothelial biosecretory, migratory, and proliferative functionality that is perhaps more physiological and robust than the conventional two-dimensional state of plated cultures [20], [21], [22], [23], [24]. The three-dimensional state offers the opportunity to consider external mechanical and cell

Influence of matrix composition on endothelial cell phenotype

Matrix environment influences pivotal endothelial cell functions: receptors for the extracellular matrix, in particular the integrins, act not only to provide anchorage for endothelial cells, but also provide information about the local microenvironment that facilitates their decision to proliferate, migrate or die [33] and mediate endothelial permeability [34]. Integrins actively affect intracellular signaling, e.g., via focal adhesion kinase, and signaling via different integrins modulates

Immune phenotype of three-dimensional matrix-embedded endothelial cells

As previously demonstrated in other cell systems intracellular cytokine signaling pathways are modulated by the surrounding tissue architecture. We therefore analyzed endothelial expression of adhesion, costimulatory and MHC molecules upon TNF-α and IFN-γ stimulation. Endothelial cells were either placed within collagen-based scaffolds (three-dimensional), grown to confluence on two-dimensional polystyrene tissue culture plates or tissue plates coated with collagen. Whereas the matrix

Interaction with immune cells

Progressive infiltration of engrafted tissues by host mononuclear cells is characteristic of acute rejection. Surprisingly, we could not detect a significant humoral or cellular rejection after implantation of matrix-embedded allo- and even xenogeneic endothelial cells in immunocompetent hosts [32]. In marked contrast to endothelial cells injected as saline suspensions, matrix-embedded endothelial cells did not evoke formation of endothelial-specific antibodies (Fig. 3) or host immune cell

Discussion

Our results corroborate others’ results that composition and spatial formation of extracellular matrix components affect cellular behavior. Yet, to the best of our knowledge our group is the first to demonstrate effects of matrix–endothelial cell connectivity for endothelial cell immunogenicity. Immune responses against cellular and non-cellular components of tissue engineered devices are becoming increasingly appreciated as potential limitations to successful therapeutic approaches. As the

Acknowledgements

Research described in this article was supported by Philip Morris USA Inc. and by Philip Morris International. Heiko Methe was supported by a grant from the Deutsche Herzstiftung, Frankfurt, Germany. Shmuel Hess was supported by the NIH Post-Doctoral Ruth L. Kirschstein Research Service Award, Elazer R. Edelman by a grant from the USA National Institutes of Health (GM 49039).

References (55)

  • J.P. Stegemann et al.

    Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture

    Exp Cell Res

    (2003)
  • S. Hehlgans et al.

    Signalling via integrins: implications for cell survival and anticancer strategies

    Biochim Biophys Acta

    (2007)
  • T.F. Luscher et al.

    Biology of the endothelium

    Clin Cardiol

    (1997)
  • R. Ross

    Atherosclerosis—an inflammatory disease

    New Engl J Med

    (1999)
  • R.S. Schwartz

    Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling

    Am J Cardiol

    (1998)
  • J. Middleton et al.

    Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky

    Arthritis Res Ther

    (2004)
  • P.M. Lowe et al.

    The endothelium in psoriasis

    Br J Dermatol

    (1995)
  • A.V. Andjelkovic et al.

    Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease

    J Neurosci Res

    (1998)
  • G.K. Hansson

    Inflammation, atherosclerosis, and coronary artery disease

    New Engl J Med

    (2005)
  • S. Danese et al.

    Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation

    J Immunol

    (2007)
  • K. Edfeldt et al.

    Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

    Circulation

    (2002)
  • H. Methe et al.

    Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation

    Transplantation

    (2004)
  • S. Dunzendorfer et al.

    Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses

    FASEB J

    (2004)
  • J. Heidemann et al.

    Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?

    Infect Immun

    (2006)
  • E. Faure et al.

    Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation

    J Immunol

    (2001)
  • J. Tissari et al.

    IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression

    J Immunol

    (2005)
  • S. Zeuke et al.

    TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS

    Cardiovasc Res

    (2002)
  • Cited by (0)

    View full text